当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
AUDENZ, Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
药品名称
AUDENZ, Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
承诺描述
Deferred pediatric study V89_19 under PREA to evaluate the safety and immunogenicity of AUDENZ when administered to healthy infants 0 to less than 6 months of age.
承诺状态描述
The study has not been initiated, but does not meet the criterion for delayed.